We found that secretion of MIP-1β, majorly contributed by hematopoietic cells, was higher in immunocompetent leukaemia chips than in immunocompromised ones after 2-day treatment of CAR T cell on-chip (Fig. 3d,e). Here, CCL4 is linked to leukemia.